Phase I study of selumetinib in Chinese pediatric and adult patients (pts) with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN): Interim results

被引：1
|
作者：
Yuan, X-J. [1 ]
Zhang, X. [1 ]
Li, Q. [2 ]
Wang, Z. [2 ]
Li, C. [3 ]
Liu, Y. [4 ]
Ge, X. [5 ]
Zhao, J. [6 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Paediat Hematol Oncol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai, Peoples R China
[3] AstraZeneca Global R&D China Co Ltd, Hematol Oncol, Shanghai, Peoples R China
[4] AstraZeneca Global R&D China Co Ltd, Biometr, Shanghai, Peoples R China
[5] AstraZeneca Global R&D China Co Ltd, Clin Safety, Shanghai, Peoples R China
[6] AstraZeneca Global R&D China Co Ltd, Clin Pharmacol, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.10.433
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
402P
引用
收藏
页码：S1599 / S1599
页数：1
相关论文
共 50 条
  • [41] Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy Y.
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei S.
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1221 - 1233
  • [42] Selumetinib for symptomatic, inoperable plexiform neurofibromas in pediatric patients with neurofibromatosis type 1: the first single-center real-world case series in Japan
    Nishida, Yoshihiro
    Nonobe, Norie
    Kidokoro, Hiroyuki
    Kato, Taichi
    Takeichi, Takuya
    Ikuta, Kunihiro
    Urakawa, Hiroshi
    Sakai, Tomohisa
    Koike, Hiroshi
    Fujito, Takeo
    Imagama, Shiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025,
  • [43] CLINICAL BURDEN AMONG PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMA (PN) IN THE UNITED STATES (US)
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy
    Sipsma, Heather
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei Sheng
    NEURO-ONCOLOGY, 2021, 23 : 41 - 42
  • [44] TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS
    Kiaei, Dorsa Sadat
    Larouche, Valerie
    Decarie, Jean-Claude
    Tabori, Uri
    Hawkins, Cynthia
    Lippe, Sarah
    Ellezam, Benjamin
    Ospina, Luis H.
    Theoret, Yves
    Desjardins, Leandra
    Metras, Marie-Elaine
    Sultan, Serge
    Cantin, Edith
    Routhier, Marie-Eve
    Mailloux, Chantal
    Bertrand, Marie-Claude
    Caru, Maxime
    McKeown, Tara
    Vairy, Stephanie
    Legault, Genevieve
    Bouffet, Eric
    Ramaswamy, Vijay
    Coltin, Hallie
    Lafay-Cousin, Lucie
    Hukin, Juliette
    Erker, Craig
    Jabado, Nada
    Dehaes, Mathieu
    Perreault, Sebastien
    NEURO-ONCOLOGY, 2022, 24 : 70 - 70
  • [45] TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS
    Kiaei, Dorsa Sadat
    Larouche, Valerie
    Decarie, Jean-Claude
    Tabori, Uri
    Hawkin, Cynthia
    Lippe, Sarah
    Ellezam, Benjamin
    Ospina, Luis H.
    Theoret, Yves
    Desjardins, Leandra
    Metras, Marie-Elaine
    Sultan, Serge
    Cantin, Edith
    Routhier, Marie-Eve
    Mailloux, Chantal
    Bertrand, Marie-Claude
    Caru, Maxime
    Vairy, Stephanie
    Legault, Genevieve
    Bouffet, Eric
    Ramaswamy, Vijay
    Coltin, Hallie
    Lafay-Cousin, Lucie
    Hukin, Juliette
    Erker, Craig
    Jabado, Nada
    Dehaes, Mathieu
    Perreault, Sebastien
    NEURO-ONCOLOGY, 2022, 24 : 129 - 129
  • [46] Management of head and neck plexiform neurofibromas in pediatric patients with neurofibromatosis type 1
    Wise, JB
    Cryer, JE
    Belasco, JB
    Jacobs, I
    Elden, L
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (08) : 712 - 718
  • [47] Population Pharmacokinetic Analysis of Selumetinib and Its N-desmethyl Metabolite in Japanese and Non-Japanese Pediatric Patients with Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas
    Shinbo, Takumi
    Higashimori, Mitsuo
    Gonzalez-Garcia, Ignacio
    Learoyd, Maria
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2024, 2024
  • [48] OBSERVATIONAL REGISTRY STUDY OF TREATMENT PRACTICES AND LONG-TERM OUTCOMES OF CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND PLEXIFORM NEUROFIBROMAS (PN) INITIATING SELUMETINIB IN REALWORLD PRACTICE IN THE UNITED STATES (US): STUDY DESIGN AND METHODOLOGY
    Waanders, Angela
    Yohay, Kaleb
    Fang, Shona
    Wahlstrom, Svea
    Bornhorst, Miriam
    Meade, Julia
    Vallance, Kelly
    Rodriguez, Randolph de la Rosa
    NEURO-ONCOLOGY, 2023, 25
  • [49] A Study of Plexiform Neurofibromas in Neurofibromatosis type 1 patients in Northern Ireland
    Donnelly, Deirdre
    Morrison, Patrick
    Harding, Siobhan
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 3) : S75 - S75
  • [50] RENEU: A PIVOTAL PHASE 2B TRIAL OF MIRDAMETINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA (PN)
    Moertel, C. L.
    Hirbe, A. C.
    Shuhaiber, H. H.
    Viskochil, D.
    Sidhu, A.
    Bielamowicz, K.
    Weber, M. D.
    Lokku, A.
    Smith, L.
    Weintraub, L.
    McNall-Knapp, R. Y.
    Hajjar, F. M.
    Foreman, N.
    Gershon, T. R.
    Babovic-Vuksanovic, D.
    NEURO-ONCOLOGY, 2024, 26 : V20 - V20
12345